Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

49.6K
Overview
49.6K
Development of Immunocompetence01:22

Development of Immunocompetence

599
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
599
International Nursing Organizations II01:28

International Nursing Organizations II

1.2K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.6K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.6K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.8K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

702
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
702

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same author

Viral variant but not host factors associate with SARS-CoV-2 viral kinetics.

Communications medicine·2026
Same author

Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures.

Frontiers in immunology·2026
Same author

Evaluation of Strongyloides stercoralis Ss-IR Recombinant Antigen Using a Bead-Based Immunoassay.

The American journal of tropical medicine and hygiene·2026
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Technology and Dementia Preconference.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Nov 29, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K

An immunization program for US-bound refugees: Development, challenges, and opportunities 2012-present.

Tarissa Mitchell1, Warren Dalal2, Alexander Klosovsky3

  • 1Immigrant, Refugee, and Migrant Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Vaccine
|November 21, 2020
PubMed
Summary
This summary is machine-generated.

A global immunization program for US-bound refugees, launched in 2012, successfully increased vaccine coverage and reduced travel cancellations. This initiative protects refugees from vaccine-preventable diseases and offers significant cost savings.

Keywords:
Emigration and immigrationImmunization programsRefugees

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.0K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.4K

Related Experiment Videos

Last Updated: Nov 29, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.4K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.0K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.4K

Area of Science:

  • Global Health
  • Preventive Medicine
  • Immigration Health

Background:

  • US-bound refugees undergo overseas health assessments for communicable diseases but lack required immunizations, posing risks.
  • A global immunization program was co-developed by the US CDC and Department of State in 2012 for US-bound refugees.
  • The program collaborates with the International Organization for Migration to administer vaccines.

Purpose of the Study:

  • To describe the Vaccination Program for US-bound Refugees.
  • To outline vaccination schedule development, program implementation, and challenge responses.
  • To estimate 2019 immunization coverage and hepatitis B infection prevalence.

Main Methods:

  • Program active in >80 countries by September 2019, with nearly 320,000 refugees receiving at least one vaccine dose.
  • Federal fiscal year 2019 saw 95% of arriving refugees with documented measles-containing vaccine.
  • Program included eleven vaccines preventing fourteen diseases; adverse events were monitored.

Main Results:

  • Significant reduction in refugee travel cancellations due to vaccine-preventable diseases (2 vs. 2-8 annually pre-program).
  • Established uniform standards through dedicated staff and specific protocols for vaccination and monitoring.
  • Hepatitis B infection prevalence data was collected via surface antigen testing.

Conclusions:

  • The overseas immunization program for US-bound refugees has been successfully implemented.
  • Anticipated cost savings from reduced travel cancellations and overseas immunization costs.
  • Program cohesion and advancement ensured through dedicated staff, protocols, and technical support, offering lessons for similar migration health programs.